Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 1991 to 2000 of 2607 total matches.

In Brief: Otrexup - A Single-Use Auto-Injector Formulation of Methotrexate

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 2014  (Issue 1439)
injection (IM or SC) for these indications for many years,1 but not specifically for self-administration ...
The FDA has approved a new injectable formulation of methotrexate (Otrexup – Antares) for use in rheumatoid arthritis and polyarticular juvenile idiopathic arthritis, and for severe psoriasis in adults. On its web site (www.otrexup.com), the manufacturer states: "Otrexup is the first subcutaneous (SC) methotrexate (MTX) for self-administration delivered once weekly by auto-injector." Methotrexate has been available as a once-weekly injection (IM or SC) for these indications for many years,1 but not specifically for self-administration and not in a single-dose auto-injector. Methotrexate is...
Med Lett Drugs Ther. 2014 Mar 31;56(1439):28 |  Show IntroductionHide Introduction

In Brief: Adding Ezetimibe to a Statin Improves Clinical Outcomes

   
The Medical Letter on Drugs and Therapeutics • Dec 08, 2014  (Issue 1457)
in high-risk patients reduces cardiovascular events.1 IMPROVE-IT compared the efficacy of simvastatin ...
Combining a statin with another drug that lowers low-density lipoprotein cholesterol (LDL-C), such as colesevelam (Welchol), niacin (Niaspan, and others), or ezetimibe (Zetia), can reduce LDL-C levels more than a statin alone, but studies convincingly demonstrating that such combinations improve clinical outcomes have been lacking. The results of a long-term randomized, double-blind clinical trial (IMPROVE-IT) recently presented at the American Heart Association's Scientific Sessions 2014 indicate that addition of ezetimibe to simvastatin in high-risk patients reduces cardiovascular...
Med Lett Drugs Ther. 2014 Dec 8;56(1457):126 |  Show IntroductionHide Introduction

Vitamin Supplements

   
The Medical Letter on Drugs and Therapeutics • Jul 18, 2005  (Issue 1213)
vitamins. Since the last Medical Letter article on this subject, 1 more data have become available ...
Many patients ask their physicians whether they should take vitamins. Since the last Medical Letter article on this subject, more data have become available on the benefits and risks of taking vitamin supplements.
Med Lett Drugs Ther. 2005 Jul 18;47(1213):57-8 |  Show IntroductionHide Introduction

Which Statin?

   
The Medical Letter on Drugs and Therapeutics • Apr 21, 2008  (Issue 1284)
and cardiovascular mortality in patients with hypercholesterolemia. 1 HIGH VERSUS LOW DOSES — Intensive statin ...
Advertisements for atorvastatin (Lipitor), the market leader facing generic competition, have been in the news recently in the US. Lovastatin, pravastatin and simvastatin are all available generically at a much lower retail price or lower co-pay than atorvastatin.
Med Lett Drugs Ther. 2008 Apr 21;50(1284):29-31 |  Show IntroductionHide Introduction

Lacosamide for Epilepsy

   
The Medical Letter on Drugs and Therapeutics • Jun 29, 2009  (Issue 1315)
generalized seizures as well. 1 IV formulations are also available for phenytoin, valproate, levetiracetam ...
The FDA has approved lacosamide (Vimpat - UCB Pharma) for oral or intravenous (IV) use as add-on therapy in adults with partial-onset seizures.
Med Lett Drugs Ther. 2009 Jun 29;51(1315):50-2 |  Show IntroductionHide Introduction

Comparison Table: Some Drugs for Gout (online only)

   
The Medical Letter on Drugs and Therapeutics • Oct 30, 2023  (Issue 1688)
x 1 dose, then 200 mg PO 12 hrs later on day 1, followed by 200 mg PO bid $16.20 937.80 ...
View the Comparison Table: Some Drugs for Gout
Med Lett Drugs Ther. 2023 Oct 30;65(1688):e176-9   doi:10.58347/tml.2023.1688c |  Show IntroductionHide Introduction

Treatment of Clostridioides difficile Infection

   
The Medical Letter on Drugs and Therapeutics • Sep 06, 2021  (Issue 1632)
. Guidelines on management of CDI have recently been updated.1-3 RISK FACTORS — Common risk factors for CDI ...
Clostridioides (formerly Clostridium) difficile infection (CDI) is the most common infectious cause of healthcare-associated diarrhea in adults. Guidelines on management of CDI have recently been updated.
Med Lett Drugs Ther. 2021 Sep 6;63(1632):137-41 |  Show IntroductionHide Introduction

Tretinoin for Aging Skin

   
The Medical Letter on Drugs and Therapeutics • Jul 15, 1988  (Issue 770)
-blind, sixteen-week study compared oncedaily application of 0.1% tretinoin cream with the vehicle alone ...
Tretinoin (all-trans-retinoic acid; Retin-A), a vitamin A metabolite used for years for topical treatment of acne, is now being used (without the approval of the US Food and Drug Administration) to improve the appearance of aging skin. Available by prescription in various concentrations in cream, gel and liquid formulations, tretinoin is chemically similar to isotretinoin (13-cis-retinoic acid; Accutane), an oral drug used for treatment of severe acne which has recently caused concern because of its teratogenicity (Morbid Mortal Weekly Rep, 37:171, March 25, 1988).
Med Lett Drugs Ther. 1988 Jul 15;30(770):69-70 |  Show IntroductionHide Introduction

NovolinPen for Insulin Injection

   
The Medical Letter on Drugs and Therapeutics • Dec 30, 1988  (Issue 782)
, compared to $2.04 for 150 units of Humulin (Lilly) and $1.61 for Iletin, according to Drug Topics Red Book ...
The NovolinPen (Squibb - Novo) is a device that uses prefilled cartridges to inject semisynthetic human insulin (Medical Letter, 25:63, 1983). Three formulations are available: regular insulin (Novolin R PenFill), NPH insulin isophane (Novolin N PenFill) and a mixture of 70% NPH and 30% regular (Novolin 70/30 PenFill). The NovolinPen is advertised as more accurate, more convenient and less expensive than conventional syringes and needles. The same device is marketed in Canada as the Novolin-Pen II (Connaught Novo). (An earlier device is also available as the Novolin-Pen in Canada and the...
Med Lett Drugs Ther. 1988 Dec 30;30(782):117-8 |  Show IntroductionHide Introduction

Misoprostol

   
The Medical Letter on Drugs and Therapeutics • Mar 10, 1989  (Issue 787)
and other agents. NSAIDs inhibit synthesis of prostaglandins (IMH Main, Postgrad Med J, 64 suppl 1:3, 1988 ...
Misoprostol (Cytotec - Searle), a synthetic methyl analog of prostaglandin E1, was recently approved by the US Food and Drug Administration for prevention of gastric ulcers in high-risk patients taking nonsteroidal anti-inflammatory drugs (NSAIDs). In other countries, the drug is also marketed for treatment of idiopathic peptic ulcers unrelated to NSAIDs.
Med Lett Drugs Ther. 1989 Mar 10;31(787):21-2 |  Show IntroductionHide Introduction